Noci Darlene sold $11K of NUVL
Noci Darlene (Chief Development Officer) sold 100 shares of Nuvalent, Inc. (NUVL) at $109.76 on 2026-05-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Insider selling disclosures can affect sentiment, but 10b5-1 plans are designed to reduce timing-based inference.
Market read
A routine 10b5-1 insider sale; likely minimal impact unless paired with other negative company-specific news.
What to watch
The sale size is small ($10,976) and the plan is pre-arranged; without additional context (e.g., multiple consecutive sales), signal strength is limited.
Background
SEC Form 4 reports insider transactions for company insiders; this one is an open-market sale by the Chief Development Officer under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Nuvalent CDO Noci Darlene sold 100 shares in an open-market transaction disclosed via SEC Form 4.
Low likelihood of sustained price impact; any effect is likely short-lived and outweighed by other catalysts.
The filing is a small, disclosed open-market sale under a pre-arranged 10b5-1 plan, which typically reduces interpretive signal.
Market effects
No clear sector read-through from a single small 10b5-1 insider sale.
None.
None.
Counterpoint
Even 10b5-1 sales can coincide with internal expectations of near-term volatility, so traders may watch for follow-on selling or other filings.
Key entities
- issuerNuvalent, Inc.
Subject of the SEC Form 4 insider transaction disclosure.
- insiderNoci Darlene
Chief Development Officer who sold 100 shares.
